Andorra Presents MeDiBREAST Study on Mediterranean Diet for Breast Cancer Patients
University of Andorra hosts presentation on prospective study testing personalized Mediterranean diet to improve gut microbiota, reduce treatment.
Key Points
- Assesses impact of personalized Mediterranean diet on gut microbiota and metabolomics in 25 breast cancer patients.
- Aims to link dietary shifts to reduced toxicity, fatigue, inflammation, and better therapy tolerance.
- Six-month program with nutritionist consultations and regular monitoring of health markers.
- Joint effort by SAAS Oncology and Nutrition Units, supported by Hospital Clínic Barcelona.
The University of Andorra (UdA) hosted a presentation on the MeDiBREAST study Thursday during its Píndoles de recerca series, which showcases scientific work carried out in the country. Dr. Cristina Royo-Cebrecos, an internal medicine specialist at Nostra Senyora de Meritxell Hospital and a University of Barcelona medical graduate, outlined the project.
The prospective research, fully titled “MeDiBREAST: Impacte de la dieta mediterrània en la microbiota, la metabolòmica i la toxicitat del tractament del càncer de mama,” will assess whether a personalized Mediterranean diet can shift gut microbiota and metabolic profiles among women receiving breast cancer treatment. The team seeks to identify links between these shifts and reduced treatment toxicity, alongside impacts on fatigue, inflammation, body composition, quality of life, and overall therapy tolerance.
Twenty-five female participants will get one-on-one advice from a nutrition expert over six months, with regular checks on microbiota, metabolomics, nutritional health, and quality-of-life measures. Researchers hope to pinpoint drivers of side effects, boost treatment outcomes, and support patient well-being and compliance.
The initiative arises from teamwork between the Oncology Unit and Dietetics and Nutrition Unit at Andorra's Servei Andorrà d'Atenció Sanitària (SAAS), backed by Barcelona's Hospital Clínic. Dr. Royo-Cebrecos said fieldwork should start in April.
The event underscores UdA's growing focus on health research, reinforced by the new Institut Universitari de Recerca en Salut (IURS). Rector Juli Minoves highlighted this priority in his closing comments.
Original Sources
This article was aggregated from the following Catalan-language sources:
- Diari d'Andorra•
La dieta mediterrània i l’efecte en el càncer de mama, a l’UdA
- Diari d'Andorra•
L'UdA presenta un estudi sobre l’impacte de la dieta mediterrània en pacients amb càncer de mama
- Bon Dia•
Un estudi analitza l'impacte de la dieta mediterrània en el tractament del càncer de mama
- Altaveu•
L'UdA presenta un estudi sobre com la dieta mediterrània pot influir en el càncer de mama